Technology
SiNON Nano Sciences are pioneering the development of a novel, effective, and targeted delivery system for administering therapeutics through oral, intravenous and other desirable routes. Our approach aims to enhance bioavailability while ensuring a slow and sustained release, maintaining the optimal concentration of therapeutics at the site of action. This cutting-edge delivery system is designed to improve therapeutic outcomes and patient experiences.
Enhanced Bioavailability: Maximizing the absorption of therapeutics through precise delivery mechanisms. Sustained Release: Ensuring prolonged therapeutic effects with controlled release for consistent efficacy.
Initial Focus Area GLIOBLASTOMA
Glioblastoma is an aggressive type of cancer that occurs in the brain. It forms from glial cells that support the nerve cells.
80,000
new cases of brain tumor in the U.S annually
>70%
morbidity rate
25-40%
of the tumors metastasize to the brain
Significant Impact: SiNON’s platform technology targets glioblastomas, aiming to significantly change patient outcomes.
Large Affected populations: Glioblastomas affect a large number of individuals, making them a key focus for our research.
Available Pharmaceuticals: Leveraging existing pharmaceuticals, our technology is positioned to enhance treatment efficacy.
Current Focus Area BLOOD BRAIN BARRIER
The Blood Brain Barrier obstructs passage and complicates treatments within the brain.
ONLY 2%
of current drugs and nano particles can cross the blood brain barrier
High Morbidity: The difficulty in delivering effective treatments to the brain contributes to a high morbidity rate.Impact on Quality of Life: Patients often experience a severe decline in their quality of life due to the lack of effective therapies.Treatment Toxicity: Many existing treatments come with high toxicity levels, leading to adverse side effects.
Four Patents Issued, Fifth Patents is in progress
Water soluble fluorescent quantum carbon dots. Nanoparticle compositions and methods of making and using the same.pH-based structural change of water soluble carbon nanoparticles for encapsulation and release of therapeutic agents.
How we Stand Out
SiNON Nano Sciences has developed a novel method of crossing the Blood Brain Barrier, which is effective, non-invasive, and ,most importantly can be utilized by almost all drugs (making even retroactive application possible).
